Biotech Analysts Fadia and Lee, along with Dr. Neha Sirohi, discuss Cogent’s SUMMIT data on bezuclastinib for indolent systemic mastocytosis presented at the American Society of Hematology (ASH) 65th Annual Meeting on an Analyst/Industry conference call to be held on December 11 at 11 am.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on COGT:
- Cogent Biosciences Reports Recent Business Highlights and Third Quarter 2023 Financial Results
- Cogent Biosciences reports Q3 EPS (64c), consensus (50c)
- Cogent Biosciences Presents Preclinical Data Highlighting Precision Oncology Pipeline at the 2023 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics